COVAXIN Vaccine Current Affairs, GK & News

WHO seeks clarifications from Bharat Biotech on Covaxin

According to World Health Organisation (WHO), additional clarifications from manufacturer are required to conduct final Emergency Use Listing (EUL) risk-benefit assessment for using Bharat Biotech’s Covaxin globally. Key Points Technical advisory group are now scheduled to meet on November 3 for final assessment. Bharat Biotech has been submitting data on rolling basis to the WHO. ..

Month: 

Category: 

Topics: 

Covaxin approved for emergency use in 2–18-year-olds

The Subject Expert Committee on Covid-19 has approved the “emergency use” of Bharat Biotech’s Covaxin vaccine for children aged between 2-18 years old. Key Points Phase-2 and Phase-3 trials of the Covaxin vaccine by Hyderabad-based Bharat Biotech on children below the age of 18 years in the months of September. Trial data was submitted to ..

Month: 

Category: 

Topics: 

WHO Chief Scientist: Covid vaccination is not absolute protection

Chief scientist of World Health Organisation (WHO), Dr. Soumya Swaminathan, noted that though Covid-19 vaccines may not provide absolute protection against emerging variants of the coronavirus. However, it can reduce risks of death and complications. Highlights Dr Swaminathan further emphasised that, people need to be on guard in upcoming months. She noted that, in a ..

Month: 

Category: 

Topics: 

COVAXIN trial starts on children

Trial of COVAXIN, a COVID-19 vaccine by Bharat Biotech, on children below 18 years was started at All India Institute of Medical Sciences (AIIMS), Patna. Background Trail was started following a nod given on May 11 by Drugs Controller General of India (DCGI) to conduct clinical trials of Covaxin. COVAXIN was approved by DCGI, for ..

Month: 

Category: 

Topics: 

Govt to support Public Sector Companies for Vaccine Production

Union Government has decided to support some public sector companies with grants under the Mission COVID Suraksha to boost covid-19 vaccine production. Key Points Among the companies, one is Hyderabad based Indian Immunological limited (IIL), a facility under PSU named “National Dairy Development Board”. IIL and Bharat Biotech have signed a technical agreement for IIL ..

Month: 

Category: 

Topics: